Page last updated: 2024-10-28

gyki 52466 and Laryngeal Neoplasms

gyki 52466 has been researched along with Laryngeal Neoplasms in 1 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stepulak, A1
Luksch, H1
Uckermann, O1
Sifringer, M1
Rzeski, W1
Polberg, K1
Kupisz, K1
Klatka, J1
Kielbus, M1
Grabarska, A1
Marzahn, J1
Turski, L1
Ikonomidou, C1

Other Studies

1 other study available for gyki 52466 and Laryngeal Neoplasms

ArticleYear
Glutamate receptors in laryngeal cancer cells.
    Anticancer research, 2011, Volume: 31, Issue:2

    Topics: Benzodiazepines; Carcinoma, Squamous Cell; Cell Growth Processes; Cell Line, Tumor; Dizocilpine Male

2011